EUVIMEDEUVIMED entdecken
Crossref

Combined Hormonal Contraception with Low-Dose Ethinylestradiol is Associated with Modest Reduction of Breast Milk Volume when Administered Vaginally, but Not Orally

Lior Segev, Gideon Weitzman, Basem Hijazi, Guy Shrem, Hila Hochler, Yechiel Burke, Abraham O Samson iD, Naama Srebnik

Breastfeeding Medicine · 01.07.2026 · 21 (7) · 351-358

DOI: 10.1177/15568253261450161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breastfeeding Medicine, online erschienen am 14.05.2026. Verfasst von Lior Segev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Hauptthemen laut MEDLINE: Ethinyl Estradiol, Milk, Human, Breast Feeding, Lactation. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Combined hormonal contraception (CHC) is habitually not prescribed to breastfeeding women due to concerns of decreased milk production. This habit is based on inconclusive studies that examined lactation suppression of CHC with high-dose Ethinylestradiol (EE ≥ 30 µg/day). Notably, the effect of oral CHC with current low-dose EE (20 µg/day EE), and of vaginal rings (15 µg/day EE), has not yet been studied. Here, we examine their effect on breastmilk production. Study Design: This study included 172 breastfeeding women, and evaluated self-reported breastmilk production, with and without hormonal contraception. Breastfeeding women using CHC with low-dose EE, either orally ( N = 20), or vaginally ( N = 32), were asked to complete a questionnaire, at two time-points: (1) Before starting CHC, and (2) some 7–10 days after. The questionnaire recorded 12 variables linked with breastfeeding. As a control group, breastfeeding women using progestin-only pills (POP, N = 54) with Desogestrel 75 µg/day, were used. As another control group, breastfeeding women using no hormonal contraception ( N = 66) were also asked to complete the same questionnaire.

Results

Vaginal rings, but not oral CHC pills, containing low-dose EE, are associated with a reduction of self-reported expressed breastmilk volume by 20%. Likewise, vaginal rings, but not oral pills, are correlated with impairment of 5 out of 12 breastfeeding variables, namely: (1) breastfeeding interval, (2) self-expressed milk volume, (3) use of milk substitutes, (4) number of night-feedings, and (5) full diapers.

Conclusion

Vaginal rings with low-dose EE (15 µg/day) are associated with a modest, yet significant, decrease in self-expressed breastmilk volume. In contrast, oral CHC pills with low-dose EE (20 µg/day) are not associated with a significant impact on breastmilk production. These findings may have clinical implications for prescribers and patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ethinyl EstradiolMilk, HumanBreast FeedingLactationContraceptives, Oral, CombinedHormonal ContraceptionHumansFemaleAdultAdministration, IntravaginalAdministration, OralYoung AdultSurveys and Questionnaires

Stichwörter der Autor:innen

breastfeedingcombined hormonal contraceptionestradiolethinylethinylestradiolprogesterone-only pillprogestin-only pill

Substanzen

Ethinyl EstradiolContraceptives, Oral, Combined

Autor:innen und Institutionen

  • Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
  • PUAH Institute: Fertility and Medicine in Accordance with Halacha, Jerusalem, Israel.
  • Fertility Clinic, Clalit Health Services, North District, Israel.
  • Laniado Medical Center, Netanya, Israel.
  • Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.
  • IVF Unit, Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.

ORCID-Profile: Abraham O Samson

Zitieren

APA

Segev, L., Weitzman, G., Hijazi, B., Shrem, G., Hochler, H., Burke, Y., Samson, A. O., & Srebnik, N. (2026). Combined Hormonal Contraception with Low-Dose Ethinylestradiol is Associated with Modest Reduction of Breast Milk Volume when Administered Vaginally, but Not Orally. Breastfeeding Medicine, 21(7), 351-358. https://doi.org/10.1177/15568253261450161

Vancouver

Segev L, Weitzman G, Hijazi B, Shrem G, Hochler H, Burke Y, et al. Combined Hormonal Contraception with Low-Dose Ethinylestradiol is Associated with Modest Reduction of Breast Milk Volume when Administered Vaginally, but Not Orally. Breastfeeding Medicine. 2026;21(7):351-358. doi:10.1177/15568253261450161

BibTeX
@article{Segev2026,
  author = {Segev, Lior and Weitzman, Gideon and Hijazi, Basem and Shrem, Guy and Hochler, Hila and Burke, Yechiel and Samson, Abraham O and Srebnik, Naama},
  title = {Combined Hormonal Contraception with Low-Dose Ethinylestradiol is Associated with Modest Reduction of Breast Milk Volume when Administered Vaginally, but Not Orally},
  journal = {Breastfeeding Medicine},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {351--358},
  doi = {10.1177/15568253261450161}
}
Kostenlos starten →